Novel therapeutic strategies: hypomethylating agents and beyond
نویسندگان
چکیده
منابع مشابه
Therapeutic strategies in pneumonia: going beyond antibiotics.
Dysregulation of the innate immune system drives lung injury and its systemic sequelae due to breakdown of vascular barrier function, harmful hyperinflammation and microcirculatory failure, which contribute to the unfavourable outcome of patients with severe pneumonia. A variety of promising therapeutic targets have been identified and numerous innovative therapeutic approaches demonstrated to ...
متن کاملAmyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
1Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, USA 2Department of Neurosciences, University of Toledo Medical Center, Toledo, OH 43614, USA 3Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA 4Department of Neurology, Hannover Medical School, Hannover, 30625, Germany 5Center for Translational Neuroscience, Department of Neurobio...
متن کاملTherapeutic strategies for spinal muscular atrophy: SMN and beyond
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1 A second duplicated gene, SMN2, produces very little but sufficient functional protein for survival. Thera...
متن کاملCommunication Strategies Revisited: Looking beyond Interactional and Psycholinguistic Perspectives
Second language (L2) communication strategies (CSs) have traditionally been dealt with through either interactional or psychological perspectives. However, this paper is a critical attempt to question the status of the particular kinds of psycholinguistic and interactional approaches that currently dominate the field of second language acquisition (SLA). In this way, it expands the significance...
متن کاملNovel therapeutic agents in acute myeloid leukemia.
Acute myeloid leukemia (AML) is an intrinsically resistant disease. Prognosis is poor for the majority of AML patients, based on age and/or adverse biologic features. Standard therapy for AML is highly toxic and poorly tolerated, particularly by the group of older patients for whom few useful therapies exist. Allogeneic hematopoietic stem cell transplantation is an important option for patients...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hematology
سال: 2012
ISSN: 1520-4391,1520-4383
DOI: 10.1182/asheducation.v2012.1.65.3806843